Subscribe To
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...
October 7, 2021, 7:05 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...
October 7, 2021, 7:05 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...
October 7, 2021, 7:05 am
Calliditas announces acquisition of remaining genkyotex minority shares
STOCKHOLM, Oct. 7, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the c...
October 7, 2021, 2:21 am
Calliditas announces acquisition of remaining genkyotex minority shares
STOCKHOLM, Oct. 7, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the c...
October 7, 2021, 2:21 am
Calliditas announces acquisition of remaining genkyotex minority shares
STOCKHOLM, Oct. 7, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the c...
October 7, 2021, 2:21 am
Vislink and mobile viewpoint will showcase all-ip wireless streaming solutions at cabsat 2021
Hackettstown, NJ, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Vislink and Mobile Viewpoint will be exhibiting in person at this year's CABSAT 2021 event, which ...
October 6, 2021, 7:56 pm
Vislink and mobile viewpoint will showcase all-ip wireless streaming solutions at cabsat 2021
Hackettstown, NJ, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Vislink and Mobile Viewpoint will be exhibiting in person at this year's CABSAT 2021 event, which ...
October 6, 2021, 7:56 pm
Vislink and mobile viewpoint will showcase all-ip wireless streaming solutions at cabsat 2021
Hackettstown, NJ, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Vislink and Mobile Viewpoint will be exhibiting in person at this year's CABSAT 2021 event, which ...
October 6, 2021, 7:56 pm
Tauriga sciences inc. upgrades its exhibitor booth at the upcoming mjbizcon tradeshow; las vegas, nevada october 19-22, 2021
NEW YORK, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a N...
October 6, 2021, 11:51 am
Tauriga sciences inc. upgrades its exhibitor booth at the upcoming mjbizcon tradeshow; las vegas, nevada october 19-22, 2021
NEW YORK, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a N...
October 6, 2021, 11:51 am
Tauriga sciences inc. upgrades its exhibitor booth at the upcoming mjbizcon tradeshow; las vegas, nevada october 19-22, 2021
NEW YORK, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a N...
October 6, 2021, 11:51 am
Cocrystal pharma receives australian regulatory clearance to initiate phase 1 study of cc-42344 for the treatment of pandemic and seasonal influenza
BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biote...
October 6, 2021, 8:49 am
Cocrystal pharma receives australian regulatory clearance to initiate phase 1 study of cc-42344 for the treatment of pandemic and seasonal influenza
BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biote...
October 6, 2021, 8:49 am
Cocrystal pharma receives australian regulatory clearance to initiate phase 1 study of cc-42344 for the treatment of pandemic and seasonal influenza
BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biote...
October 6, 2021, 8:49 am
New preclinical data for edp-235, enanta's oral protease inhibitor specifically designed for the treatment of covid-19, to be presented at isriv-who virtual 2021 conference: covid-19, influenza and rs
WATERTOWN, Mass.--(BUSINESS WIRE)--New Preclinical Data for EDP-235, Enanta's Oral Protease Inhibitor f...
October 6, 2021, 8:16 am
New preclinical data for edp-235, enanta's oral protease inhibitor specifically designed for the treatment of covid-19, to be presented at isriv-who virtual 2021 conference: covid-19, influenza and rs
WATERTOWN, Mass.--(BUSINESS WIRE)--New Preclinical Data for EDP-235, Enanta's Oral Protease Inhibitor f...
October 6, 2021, 8:16 am
New preclinical data for edp-235, enanta's oral protease inhibitor specifically designed for the treatment of covid-19, to be presented at isriv-who virtual 2021 conference: covid-19, influenza and rs
WATERTOWN, Mass.--(BUSINESS WIRE)--New Preclinical Data for EDP-235, Enanta's Oral Protease Inhibitor f...
October 6, 2021, 8:16 am